Resources & Guides
Educational content about GLP-1 medications, pharmacokinetics, and optimizing your treatment journey.
GLP-1 Medication Hubs
Comprehensive guides for each GLP-1 medication—dosing protocols, clinical trial data, microdosing strategies, and our free calculators.
Semaglutide Guide
Ozempic & Wegovy: GLP-1 receptor agonist. ~15% weight loss, 7-day half-life. FDA-approved for diabetes and weight management.
Tirzepatide Guide
Mounjaro & Zepbound: Dual GLP-1/GIP agonist. ~21% weight loss, 5-day half-life. The first dual-agonist approved by FDA.
Retatrutide Guide
Triple GLP-1/GIP/Glucagon agonist. ~24% weight loss in trials, 6-day half-life. Expected FDA approval 2027.
Educational Content
Microdosing Retatrutide (GLP-3): Chart, Schedules & Doses
insightsWhile retatrutide is designed for weekly dosing, emerging interest in microdosing raises questions about splitting doses to optimize tolerability and efficacy. We examine the science, community experiences, and critical considerations.
Retatrutide Dosage Chart: 2mg to 12mg Week-by-Week Schedule
guidesComplete GLP-3 retatrutide dosage chart showing the Phase 2/3 clinical trial titration from 2mg to 12mg weekly. Includes what to expect at each dose, weight loss results by tier, side effects data, printable download, and free dosing calculator.
Retatrutide Guide: Dosing, Results, Calculator & Side Effects (2026)
hubThe ultimate retatrutide resource hub. Learn about this investigational triple-agonist, its remarkable Phase 2 results, dosing schedules, microdosing protocols, and use our free calculator to plan your journey.
Retatrutide (GLP-3) Dosing Guide: 2mg to 12mg Protocol
guidesComplete GLP-3 retatrutide dosage guide covering the 2mg to 12mg weekly titration protocol, printable dosing chart, half-life pharmacokinetics, weight loss results from clinical trials, side effects management, and a free interactive dosing calculator.
Getting Started with GLP-1 Medications: Eligibility, Dosing, and What to Expect
guideWho qualifies for GLP-1 therapy, how to get started, what to inject and when, and what to expect each week, with clinical trial data and pharmacokinetic context.